SEC Form 3 · accession 0001213900-18-009809
Compass Therapeutics, Inc. · CMPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark N. Tompkins
Director · 10% Owner
Period of report
Jul 29, 2018
Accepted (ET)
Jul 30, 2018 · 6:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001738021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 | holding | — | — | — | 4,750,000 | D |
Table II — derivative securities
No Table II lines on this filing.